Naturhouse Health SA
Naturhouse Health, S.A. operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and food and drinks, such as diet products for breakfast, snacks, and meal substitutes. It also offers cosmetics and body care products, including be… Read more
Naturhouse Health SA (NTH) - Net Assets
Latest net assets as of June 2025: €25.84 Million EUR
Based on the latest financial reports, Naturhouse Health SA (NTH) has net assets worth €25.84 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€43.70 Million) and total liabilities (€17.86 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €25.84 Million |
| % of Total Assets | 59.13% |
| Annual Growth Rate | 7.65% |
| 5-Year Change | 21.74% |
| 10-Year Change | 43.93% |
| Growth Volatility | 25.08 |
Naturhouse Health SA - Net Assets Trend (2010–2024)
This chart illustrates how Naturhouse Health SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Naturhouse Health SA (2010–2024)
The table below shows the annual net assets of Naturhouse Health SA from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €31.69 Million | +3.44% |
| 2023-12-31 | €30.63 Million | +9.95% |
| 2022-12-31 | €27.86 Million | -22.78% |
| 2021-12-31 | €36.08 Million | +38.62% |
| 2020-12-31 | €26.03 Million | +57.61% |
| 2019-12-31 | €16.51 Million | -12.35% |
| 2018-12-31 | €18.84 Million | -23.11% |
| 2017-12-31 | €24.50 Million | -9.74% |
| 2016-12-31 | €27.15 Million | +23.30% |
| 2015-12-31 | €22.02 Million | +43.23% |
| 2014-12-31 | €15.37 Million | +21.93% |
| 2013-12-31 | €12.61 Million | +7.30% |
| 2012-12-31 | €11.75 Million | -19.04% |
| 2011-12-31 | €14.51 Million | +28.61% |
| 2010-12-31 | €11.28 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Naturhouse Health SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 92.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €9.86 Million | 31.13% |
| Common Stock | €3.00 Million | 9.47% |
| Other Comprehensive Income | €22.81 Million | 72.00% |
| Total Equity | €31.68 Million | 100.00% |
Naturhouse Health SA Competitors by Market Cap
The table below lists competitors of Naturhouse Health SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PT Multikarya Asia Pacific Ray
JK:MKAP
|
$34.97 Million |
|
Loop Industries Inc
NASDAQ:LOOP
|
$34.98 Million |
|
Sonmez Pamuklu Sanayii AS
IS:SNPAM
|
$34.98 Million |
|
Phunware Inc
NASDAQ:PHUN
|
$34.99 Million |
|
Banco Hipotecario SA
BA:BHIP
|
$34.96 Million |
|
Complex Micro Interconnection Co. Ltd.
TW:6835
|
$34.95 Million |
|
EXACOMPTA CLAIREF. NOM.
F:8KG
|
$34.95 Million |
|
AUUAF
PINK:AUUAF
|
$34.94 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Naturhouse Health SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 30,627,000 to 31,681,000, a change of 1,054,000 (3.4%).
- Net income of 9,863,000 contributed positively to equity growth.
- Dividend payments of 12,000,000 reduced retained earnings.
- Other comprehensive income increased equity by 2,484,000.
- Other factors increased equity by 707,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €9.86 Million | +31.13% |
| Dividends Paid | €12.00 Million | -37.88% |
| Other Comprehensive Income | €2.48 Million | +7.84% |
| Other Changes | €707.00K | +2.23% |
| Total Change | €- | 3.44% |
Book Value vs Market Value Analysis
This analysis compares Naturhouse Health SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.96x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.97x to 4.96x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | €1.33 | €2.62 | x |
| 2013-12-31 | €1.17 | €2.62 | x |
| 2014-12-31 | €0.25 | €2.62 | x |
| 2015-12-31 | €0.36 | €2.62 | x |
| 2016-12-31 | €0.45 | €2.62 | x |
| 2017-12-31 | €0.41 | €2.62 | x |
| 2018-12-31 | €0.31 | €2.62 | x |
| 2019-12-31 | €0.27 | €2.62 | x |
| 2020-12-31 | €0.43 | €2.62 | x |
| 2021-12-31 | €0.60 | €2.62 | x |
| 2022-12-31 | €0.46 | €2.62 | x |
| 2023-12-31 | €0.51 | €2.62 | x |
| 2024-12-31 | €0.53 | €2.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Naturhouse Health SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 31.13%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 19.96%
- • Asset Turnover: 1.16x
- • Equity Multiplier: 1.34x
- Recent ROE (31.13%) is below the historical average (66.40%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 35.39% | 6.53% | 0.98x | 5.54x | €2.71 Million |
| 2013 | 72.83% | 14.27% | 1.31x | 3.90x | €7.37 Million |
| 2014 | 148.25% | 23.57% | 2.30x | 2.74x | €21.04 Million |
| 2015 | 104.60% | 23.86% | 2.32x | 1.89x | €20.67 Million |
| 2016 | 83.02% | 23.01% | 2.26x | 1.60x | €19.79 Million |
| 2017 | 81.12% | 20.97% | 2.44x | 1.59x | €17.41 Million |
| 2018 | 81.62% | 17.61% | 2.56x | 1.81x | €13.49 Million |
| 2019 | 80.58% | 16.23% | 2.17x | 2.28x | €11.61 Million |
| 2020 | 36.12% | 17.03% | 1.29x | 1.64x | €6.78 Million |
| 2021 | 37.09% | 23.20% | 1.18x | 1.36x | €9.76 Million |
| 2022 | 34.62% | 18.37% | 1.22x | 1.54x | €6.85 Million |
| 2023 | 36.87% | 22.40% | 1.03x | 1.59x | €8.23 Million |
| 2024 | 31.13% | 19.96% | 1.16x | 1.34x | €6.69 Million |
Industry Comparison
This section compares Naturhouse Health SA's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $165,570,000,000
- Average return on equity (ROE) among peers: 0.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Naturhouse Health SA (NTH) | €25.84 Million | 35.39% | 0.69x | $34.96 Million |
| Ebro Foods (EBRO) | $165.57 Billion | 0.00% | 1.13x | $935.66 Million |